found that SLC7A11-AS1 targeted miR-33a-5p and changed the expression of xCT, weakened cell growth, promoted ROS levels, and regulated cisplatin resistance in gastric cancer (34). This evidence concerns the gene SLC7A11 and gastric cancer.